Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT07287332
Eligibility Criteria:
Inclusion Criteria:
* Adults ≥18 years of age
* Admitted to one of the ICUs at the study center
* Prescribed cefepime therapy by the care team
Exclusion Criteria:
* Individuals will be those with a cephalosporin allergy
* Received \>1 dose of cefepime in the 24 hours before ICU admission
* Transferred from an external hospital without compatible EHR
* Does not have a cystatin C and a creatinine available for drug dosing
* Acute kidney injury stage 2 or higher
* Receiving renal replacement therapy
* Treated with extracorporeal membrane oxygenation
* Undergoing molecular adsorbent recirculating therapy at the time of beta-lactam initiation
* Pregnant
* Incarcerated
* Declined Minnesota research authorization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07287332
Study Brief:
Protocol Section:
NCT07287332